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Previous studies have suggested that both inflammatory monocytes and neutrophils are important for
controlling acute toxoplasmosis in the mouse model. To test the role of these cell types, we used monoclonal
antibody (MAb) RB6-8C5 to deplete both subsets of cells or MAb 1A8 to selectively remove neutrophils.
RB6-8C5 MAb-treated mice succumbed to oral infection with Toxoplasma gondii, similar to Ccr2/ mice,
which are deficient in monocyte recruitment but have normal neutrophils. In contrast, mice treated with MAb
1A8 controlled parasite replication and survived acute infection. Ccr2/ mice suffered from acute ileitis and
inflammation in the spleen that was associated with a lack of inflammatory monocytes and elevated numbers
of neutrophils. RB6-8C5 MAb-treated C57BL/6 mice also suffered from intestinal pathology and splenic
damage, although this was less extensive due to the reduced numbers of neutrophils. Neutrophil-depleted
infected wild-type mice displayed no pathological changes, compared to untreated infected controls. Collec-
tively, these observations demonstrate the critical role of inflammatory monocytes during the acute infection
with the parasite T. gondii and reveal that neutrophils are not protective but rather contribute to the pathology.
The intracellular parasite Toxoplasma gondii is an opportu-
nistic pathogen that infects approximately one-third of the
human population worldwide (19). Following oral infection,
the parasite crosses the intestinal epithelium, disseminates
widely, and traverses biological barriers such as the blood-
brain barrier to reach immunologically privileged sites, where
it causes the most severe pathology (3). Histopathological
studies document initial invasion into a variety of cell types in
the intestine, including CD11b and CD11c intraepithelial
leukocytes, which have been implicated in dissemination of the
parasite (11). We previously demonstrated that the numbers of
Gr1 inflammatory monocytes dramatically increase in the
lamina propria of the small intestine in response to T. gondii
infection and that these cells play a crucial role in protection
against the parasite (14).
Murine monocytes have been classified in two subpopula-
tions based on different surface markers and phenotypic char-
acteristics (17, 18). Inflammatory monocytes (CD115, Gr1,
F4/80, CD11b, and CX3CR1
lo) express chemokine receptor
2 (CCR2), emerge from the bone marrow in response to che-
mokines such as MCP1 (CCL2), and home to sites of inflam-
mation (17, 18). These precursors have the potential to
differentiate into dendritic cells (CD11c) and to populate
nonlymphoid tissues such as the lamina propria (33). The other
major subset of monocytes (Gr1, F4/80, CD11b, and
CX3CR1
hi) are primarily distributed as resident tissue macro-
phages, which provide surveillance functions (2). Following
oral challenge with T. gondii, inflammatory monocytes upregu-
late inducible nitric oxide synthase (iNOS), produce interleu-
kin-12 (IL-12), and secreted tumor necrosis factor alpha
(TNF-) in response to T. gondii infection (23, 24). Collec-
tively, these responses likely contribute to the control of par-
asite replication at the site of primary infection in the small
intestine (14). Mice deleted in the gene for chemokine recep-
tor 2 (CCR2), or the major chemokine ligand (CCL2) for this
receptor, fail to recruit inflammatory monocytes to the lamina
propria in response to T. gondii infection (14). The resulting
inability to control parasite replication within the small intes-
tine is associated with neutrophil efflux, tissue destruction, and
death of mice due to intestinal necrosis (14). Damage to the
small intestine following oral infection with T. gondii is also
decreased by the genetic absence of the IL-17 receptor (IL-
17R), implicating a role for neutrophils in this pathology (20).
Collectively, these findings establish the critical role of inflam-
matory monocytes in innate mucosal immunity but suggest that
neutrophils may contribute to enhanced pathology.
Neutrophils contain numerous potent antimicrobial effec-
tors, and they rapidly accumulate at the sites of many bacterial
infections (21). Neutrophils produce several cytokines and che-
mokines, such as IL-1, IL-12, TNF-, MIP-1, and MIP-2, and
hence, they recruit and activate other immune cells (27). There
is also evidence that neutrophils influence the T-cell response
by enhancing the functions of dendritic cells (32) or inflamma-
tory monocytes (30). Infection of mice by intraperitoneal (i.p.)
inoculation with low numbers of a highly virulent strain of T.
gondii or with a high inoculum of low-virulence strains results
in recruitment of neutrophils to the peritoneal cavity (4, 22).
Mouse and human neutrophils challenged in vitro with T. gon-
dii also produce IL-12, TNF-, MIP-1, and MIP-1 (6, 7). It
has been suggested that neutrophils are protective during
acute toxoplasmosis in the mouse based on depletion with
MAb RB6-8C5 (5, 26), which results in enhanced susceptibil-
ity. However, much more modest effects are observed in mice
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lacking the major neutrophil chemokine receptor CXCR2, and
these animals survive acute infection but develop slightly
higher chronic tissue burdens (13). These apparently discor-
dant results might reflect the different genetic backgrounds
used in these prior studies, since antibody depletion studies
were done with susceptible C57BL/6 mice, while CXCR2/
mice were in the resistant BALB/c background.
The anti-granulocyte receptor 1 (Gr1) monoclonal antibody
(MAb) RB6-8C5 has been used extensively to deplete neutro-
phils in mice and to investigate the role of these cells in host
defense to bacterial and protozoal infections (8–10, 21, 31).
RB6-8C5 binds to Ly6G, which is present on the surface of
neutrophils, and to Ly6C, which is expressed on neutrophils,
dendritic cells, and subpopulations of lymphocytes and mono-
cytes (15). In vivo administration of RB6-8C5 depletes not only
neutrophils (CD11b, F4/80, Ly6Cint [where int is interme-
diate], and Ly6Ghi) but also inflammatory monocytes
(CD11b, F4/80, Ly6Chi, and Ly6G) (12), thus complicating
the interpretation of studies using this antibody for neutraliza-
tion. The Ly6G-specific MAb 1A8 has recently been reported
to be an alternative method to selectively deplete neutrophils
(12).
In the present study, we sought to determine the respec-
tive roles of inflammatory monocytes and neutrophils in the
pathogenesis and control of T. gondii in mice. We compared
the outcome of oral challenge with T. gondii in mice de-
pleted of neutrophils and monocytes with MAb RB6-8C5
and that of mice where neutrophils were selectively depleted
with MAb 1A8.
MATERIALS AND METHODS
Parasite strains and mouse infections. The luciferase-expressing PRU-Luc-
GFP type II strain (provided by J. Boothroyd, Stanford University, Palo Alto,
CA) of T. gondii was used for production of tissue cysts in CD1 outbred mice
(Charles River Laboratories, Wilmington, MA). Tissue cysts used in experiments
were obtained at 3 months postinfection from mice that were inoculated with 20
cysts by i.p. injection. Animals were sacrificed, the brains were removed and
homogenized in 1 ml of phosphate-buffered saline (PBS) at pH 7.2, and tissue
cysts were counted by microscopic examination of three or more aliquots of 20
l. For challenge studies, 8- to 10-week-old female mice were used for all studies.
Mice were infected orally (p.o.) with 20 cysts, and survival was followed for 25
days. CD1 mice were obtained from Charles River Laboratories, and C57BL/6
mice were obtained from Jackson Laboratories. Ccr2/ mice fully backcrossed
onto a C57BL/6J background were described previously (24). Animals were
maintained in an AAALAC-approved facility overseen by the Institutional An-
imal Care Committee at Washington University.
Depletion of cell subsets. Neutrophils were depleted using anti-Ly6G MAb
1A8 (provided by Thomas Malek, University of Miami School of Medicine,
Miami, FL). Monocytes and neutrophils were depleted using MAb RB6-8C5
(provided by Robert L. Coffman, DNAX Research Institute, Palo Alto, CA).
Antibodies were produced by growing the respective hybridomas in serum-free
medium in CELLine flasks (IBA Integra Biosciences). The concentrations of
IgG in supernatant fractions were estimated by resolution on 10% sodium do-
decyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) gels stained with
Coomassie blue in comparison to known standards. Antibodies were adminis-
tered by i.p. injection starting on day 0 and continuing daily until day 5 postin-
fection. Injections comprised 500 g for MAb 1A8 and 250 g for MAb RB6.
Parasite burdens. For bioluminescence experiments, animals were imaged at
2-day intervals, following mild anesthesia using isofluorene and i.p. injection of
0.15 mg of luciferin D (Biosynth AG) per kg of body weight. Animals were
imaged using a Xenogen IVIS 100 (Caliper Life Sciences). Data are expressed in
relative light units and are shown as the mean results. Experiments contained 3
to 5 animals per group (except a single animal was used for the noninfected
negative control).
Cytokine levels in serum samples. Blood samples were obtained from anes-
thetized animals by heart puncturing at 6 days postinfection and centrifuged, and
the sera were stored at 80°C. Sera were diluted and used to detect cytokines
and chemokines (IL-12, gamma interferon [IFN-], and TNF-) using the cyto-
kine bead array kit from BD Biosciences (San Jose, CA). Experiments were
repeated three or more times, with 3 animals per group.
Cell isolation. Peritoneal cells were obtained by lavaging with Hanks balanced
salt solution (HBSS) containing 10 mM HEPES and 0.1 mM EGTA. Spleen cells
were isolated by mechanical disruption with frosted glass slides. Erythrocytes
were lysed with erythrocyte (RBC) lysis buffer (eBioscience, San Diego, CA).
Cell suspensions were filtered through a 40-m nylon sieve, washed twice by
centrifugation at 300  g for 10 min, and used immediately for flow cytometric
analysis. Circulating leukocytes were obtained from heparinized blood that was
diluted in Dulbecco modified Eagle medium (DMEM) containing 10% fetal
bovine serum (FBS) and layered on top of 60% isotonic Percoll. After centrif-
ugation, the buffy coat was collected and washed in PBS. Experiments were
repeated three or more times, with 3 animals per group.
Flow cytometry. Isolated cells were pretreated on ice for 20 min with MAb
2.4G2 (2.0 g/ml) to block nonspecific binding to Fc receptors. Thereafter, cells
were incubated on ice for 30 min, using the following fluorescently conjugated
antibodies for cell surface markers: Cy5-conjugated anti-Gr1 MAb RB6-8C5
(eBioscience, San Diego, CA), phycoerythrin (PE)- or allophycocyanin (APC)-
conjugated anti-F4/80 MAb A3-1 (AbD Serotec, Raleigh, NC), APC-conjugated
anti-CD115 MAb (eBioscience, San Diego, CA), APC-conjugated anti-CD11b
MAb (eBioscience, San Diego, CA), fluorescein isothiocyanate (FITC)-conju-
gated anti-Ly6C MAb AL-21 (BD Biosciences), and PE-conjugated anti-Ly6G
MAb 1A8 (BD Biosciences). Isotype controls used were PE-conjugated IgG2b,
Cy5-conjugated IgG2b (eBioscience), and FITC-conjugated rat IgG (eBio-
science). Analysis of stained cells was performed with a FACSCanto flow cytom-
eter (BD Biosciences). Dead cells were gated out on the basis of 7-AAD staining,
and isotype controls were used to set appropriate gates. Data were analyzed with
FACSDiva (BD Biosciences) and FlowJo 6.4.7 (Tree Star, Ashland, OR). For all
samples, approximately 20,000 cells were analyzed to generate scatter plots.
Histological studies. Animals were sacrificed at 9 days postinfection, and the
spleen and ileum were removed and fixed in 10% neutral buffered formalin.
Tissues were dehydrated in ethanol and embedded in paraffin, and 5-m sections
were stained with hematoxylin and eosin (H&E). Sections were evaluated blindly
to score pathological changes. Experiments were repeated three or more times,
with 3 animals per group.
Statistical analysis. Samples were compared using the unpaired Student t test
(two-tailed), with equal variance and unpaired samples, and calculated using
Excel (Microsoft, Seattle, WA).
RESULTS
In vivo depletion of neutrophils and/or inflammatory mono-
cytes using specific antibodies. To establish conditions for se-
lective depletion in vivo, we tested the ability of antibodies to
deplete inflammatory cells that were elicited by i.p. infection of
T. gondii tachyzoites. Infection with T. gondii elicited both
neutrophils (Gr1hi, Ly6Cint, Ly6G, F4/80) and inflammatory
monocytes (Gr1int, Ly6Chi, Ly6G, F4/80) (Fig. 1A), as de-
scribed previously (23). Mice were given either MAb RB6-8C5
or 1A8 on days 1 and 3, and cell recruitment to the peritoneal
cavity was tested on day 4 by flow cytometry. Application of
MAb 1A8 depleted only the neutrophil cell population (Gr1hi,
Ly6Cint, Ly6G, F4/80), while inflammatory monocytes re-
mained unaltered (Fig. 1B). Treatment with MAb RB6-8C5
depleted both inflammatory monocytes and neutrophils from
the peritoneal cavity of mice (Fig. 1C). These findings demon-
strate that selective depletion of neutrophils can be achieved
with MAb 1A8, while MAb BR6-8C5 effectively depletes both
neutrophils and monocytes, as reported previously (12).
Characterization of circulating blood leukocytes and cyto-
kine levels after depletion of neutrophils and inflammatory
monocytes. To confirm the extent of cellular depletion in an-
tibody-treated mice, blood leukocytes were isolated and char-
acterized by fluorescence staining and flow cytometry. When
animals were given neutralizing antibodies every 48 h, the
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efficiency of depletion by MAb 1A8 was reduced, especially in
lymphatic organs such as the spleen (data not shown). Instead,
animals were given daily doses of neutralizing antibodies from
day 0 to 5, and the efficiency of depletions was monitored in the
blood and spleen at day 6 (Fig. 2). To provide more-specific
labeling of the respective cell populations, we used MAb
AL-21 to Ly6C (high on monocytes and intermediate on neu-
trophils) and anti-mouse CD115, which is present on blood
monocytes but not neutrophils. In infected control mice, ele-
vated levels of inflammatory monocytes (Ly6Chi and CD115)
and neutrophils (Ly6Cint and CD115) were detected in the
blood, compared to noninfected mice (Fig. 2A). Similar results
were observed in the spleen, where neutrophils (CD11b and
Ly6Cint) and inflammatory monocytes (CD11b and Ly6Chi)
were increased in infected animals relative to noninfected con-
trols (Fig. 2B). In infected C57BL/6 mice treated with MAb
1A8, the numbers of neutrophils were reduced by 3-fold, to
levels equivalent to those seen in noninfected animals (Fig. 2A
and B). In infected C57BL/6 mice treated with RB6-8C5 MAb,
both inflammatory monocytes and neutrophils were efficiently
depleted (Fig. 2A and B). Ccr2/ mice showed elevated num-
bers of neutrophils, while inflammatory monocytes remained
largely absent from the blood (Fig. 2A and B). Treatment of
Ccr2/ mice with MAb 1A8 reduced the level of neutrophils to
a level comparable to that of noninfected mice (Fig. 2A and B).
Next, we examined the effects of alterations in inflammatory
monocytes and neutrophils on cytokine production. To this
end, serum cytokines were analyzed from T. gondii-infected
mice treated with neutralizing antibodies from day 0 to 5 and
tested 6 days postinfection. Cytokine levels were elevated in all
infected mice, indicating that the cause of death was not due to
failure to mount a type 1 cytokine response. The sera obtained
from Ccr2/ mice showed elevated levels of IFN-, IL-12,
and TNF-, although only the IFN- levels were significantly
higher than those of control infected mice (Fig. 3). Treatment
of Ccr2/ mice with MAb 1A8 to deplete neutrophils resulted
in diminished levels of all three cytokines, although only the
difference in the level of IL-12 was statistically significant
(Fig. 3).
Susceptibility of C57BL/6 mice to T. gondii infection follow-
ing depletion of neutrophils and/or inflammatory monocytes.
Having established efficient conditions to deplete cells, we di-
rectly compared the survival of C57BL/6 mice that were de-
pleted of leukocyte subsets and the survival of those that were
orally challenged with T. gondii. Ccr2/ mice on a C57BL/6
background were used for a comparison, as they are deficient
in inflammatory monocyte recruitment to the site of the infec-
tion (14). Infected wild-type mice and the majority of MAb
1A8-treated mice survived the infection (Fig. 4A). In contrast,
all RB6-8C5 MAb-treated mice and Ccr2/ mice succumbed
to the infection within 14 days, indicating a requirement for
inflammatory monocytes (Fig. 4A). Parasite replication also
was monitored in living mice by luciferase imaging (Fig. 4B).
Ccr2/ mice and MAb RB6-8C5-treated mice were unable to
control parasite replication, and parasite burdens reached very
high levels prior to death (Fig. 4B). In contrast, low parasite
numbers were observed in mice treated with MAb 1A8 and in
control mice, indicating their ability to control parasite repli-
cation (Fig. 4B).
Ccr2/mice and RB6-8C5 MAb-treated C57BL/6 mice suf-
fer from ileitis and inflammation of the spleen following in-
fection with T gondii. To investigate whether lethal T. gondii
infection was associated with pathological changes in the ileum
and spleen, mice were examined at day 9 after infection with T.
gondii. In mice treated with MAb 1A8, the small intestine
appeared similar to that in control infected mice and was
typified by an absence of cellular pathology (Fig. 5A). RB6-
8C5-treated mice had abundant apoptotic foci in the lamina
propria and edema in the overlying epithelium, although dam-
age was less extensive (Fig. 5A). Ccr2/ mice suffered from
extensive necrosis of the small intestine, massive lymphoid
depletion, and infiltration of neutrophils in the lamina propria
(Fig. 5A). Pathological changes seen in Ccr2/ mice were
partially offset by the administration of MAb 1A8, resulting in
reduced neutrophil influx and overall less damage to the villus
architecture (Fig. 5A).
We also analyzed pathological changes in the spleens of mice at
day 9 after infection with T. gondii. The spleens of 1A8-treated
mice showed only mild reduction of lymphocytes and low num-
bers of parasites, similar to those shown in control infected mice
(Fig. 5B). RB6-8C5-treated mice also showed foci of parasites,
depletion of lymphocytes, and infiltration of macrophages (Fig.
5B). Foci of parasites, marked lymphocyte depletion, and signif-
icant accumulation of neutrophils were observed in the spleens of
infected Ccr2/ mice (Fig. 5B). Treatment of Ccr2/ mice with
MAb 1A8 resulted in less influx of neutrophils, although lesions
containing parasites persisted.
FIG. 1. Flow cytometry analysis of peritoneal cells from T. gondii-
infected mice following in vivo administration of depleting antibodies.
(A) Inflammatory monocytes (Gr1int, Ly6Chi, Ly6G, and F4/80)
(circular gate  percentage of these cells) and neutrophils (Gr1hi,
Ly6Cint, Ly6G, and F4/80) (square gate percentage of these cells)
were increased in the peritoneal cavity of control mice at day 4 fol-
lowing T. gondii infection. (B) Monocytes remained elevated, while
neutrophils were depleted in the peritoneal cavities of those treated
with MAb 1A8. (C) Inflammatory monocytes and neutrophils were
absent in the peritoneal cavities of mice after administration of MAb
RB6-8C5. CD1 mice were infected i.p. with 200 tachyzoites of type II
(PRU-Luc-GFP) T. gondii 4 days before the cell isolation. Antibodies
were administered on day 1 and day 3 after the infection. Represen-
tative example obtained from four similar experiments, with 2 mice
each.
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Previous studies have suggested that neutrophils (5, 13) and
inflammatory monocytes (14, 23, 24) are important for control
of toxoplasmosis in the mouse. However, differences in exper-
imental models have made it difficult to directly compare these
results and to determine the relative importance of these cell
types during acute infection. Here we used selective depletion
of neutrophils using MAb 1A8 that reacts specifically to Ly6G
(12) and compared this to depletion of both inflammatory
monocytes and neutrophils using the previously characterized
MAb RB6-8C5, which reacts to both Ly6G and Ly6C (15).
Because Ly6C is found on monocytes and neutrophils, treat-
ment with this antibody removes both subsets efficiently. Our
studies revealed a strong phenotype when both cell types were
FIG. 2. Depletion of monocytes and neutrophils in the peripheral blood and spleen of mice treated with neutralizing antibodies and infected
with T. gondii. (A) Characterization of circulating blood leukocyte subsets by flow cytometry. Inflammatory monocytes (Ly6Chi and CD115) and
neutrophils (Ly6Cint and CD115) were defined by the indicated boxes (numbers represent percentages of cells). (B) Characterization of leukocyte
subsets from the spleen using flow cytometry. Inflammatory monocytes (Ly6Chi and CD11b) and neutrophils (Ly6Cint and CD11b) were defined
by the indicated boxes (numbers represent percentages of cells). Elevated levels of inflammatory monocytes and neutrophils were present in the
blood and spleen of infected control mice (wild-type [WT] control infected) compared to those of noninfected mice (WT control noninfected). 1A8
treatment of control (WT  1A8) and Ccr2/ (Ccr2/  1A8) mice reduced neutrophil numbers by 3-fold, resulting in levels similar to those
of noninfected controls. RB6-8C5 treatment (WT  RB6) efficiently depleted both inflammatory monocytes and neutrophils. Infected Ccr2/
mice (Ccr2/) lacked inflammatory monocytes, but neutrophils were present in higher numbers, similar to those of infected control mice.
Antibodies were applied every day from day 0 to 5 after infection, and cells were isolated at day 6. Experiments were repeated three times, with
2 animals in each group. Plots are the results obtained from representative animals from one experiment.
FIG. 3. Serum cytokine levels of mice after infection with T. gondii. Significantly elevated levels of IFN- were measured in Ccr2/ mice
(Ccr2/) compared to those in infected control mice (WT). IL-12 and TNF- levels were also elevated in Ccr2/ mice although not significantly.
Administration of MAb 1A8 to Ccr2/ mice reduced IFN- and TNF- levels and significantly reduced IL-12 levels. Neutralizing antibodies
(shown beneath the bars) were applied daily from day 0 to 5, and sera were collected on day 6 after p.o. infection with T. gondii. Three or more
experiments were combined. Values represent the means 	 SEM. *, P 
 0.05; **, P 
 0.01.
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depleted yet surprisingly little change when neutrophils alone
were depleted. Combined with the results of infection in mice
with a genetic defect in Ccr2/, which results in an inability to
recruit inflammatory monocytes (28), these results reveal that
inflammatory monocytes are required for control of acute toxo-
plasmosis in the murine model. In contrast, neutrophils do not
appear to be essential for control of acute infection and instead
may increase pathology. Since RB6-8C5 has been used exten-
sively to study other bacterial and protozoal infections, the
relative importance of inflammatory monocytes versus neutro-
phils in these other systems should also be reconsidered.
Mouse monocytes have been divided into two main popula-
tions based on phenotypic markers, migratory patterns, and
their cellular phenotypes (18). Inflammatory monocytes exit
from the bone marrow and are recruited to sites of inflamma-
tion (18). These cells express Gr1 and also the chemokine
receptor CCR2, which responds to MCP1 (CCL2). We previ-
ously reported that i.p. oral infection with type II strains of T.
gondii results in recruitment of inflammatory monocytes
(CCR2, Gr1int, Ly6Chi, Ly6G, F4/80, and CD11b) to the
peritoneal cavity (23, 24). Following oral infection, similar in-
flammatory monocytes are specifically recruited to the lamina
propria (14). Inflammatory monocytes recruited in response to
T. gondii express iNOS and TNF- (14, 23), which are essential
mediators for the control of parasite replication by activated
macrophages (1, 29). Consistent with this, inflammatory mono-
cytes are able to prevent replication of T. gondii in vitro (23),
suggesting they are also involved in the control of parasite
expansion in vivo. Mice lacking the chemokine receptor CCR2
are unable to mobilize inflammatory monocytes from the
blood (28) and, hence, are highly susceptible to acute toxoplas-
mosis (23, 24). Collectively, these studies indicate that inflam-
matory monocytes are critical for the control of acute infec-
tion, presumably acting as a first line of defense following i.p.
(24) or oral (14) challenge.
Neutrophils are primary responder cells that home to sites of
inflammation in response to chemokines such as KC (CXCL1)
and MIP-2 (CXCL2) that signal through CXCR2 (16). They
are phagocytic and express potent antimicrobial responses,
including defensins, proteases, hydrolases, and reactive oxygen
products (21). Neutrophils have been implicated in the control
of a variety of bacterial infections and inherited genetic disor-
ders that affect neutrophil function, resulting in profound sus-
ceptibility to bacterial infections. The role for neutrophils in
combating infection has partially been established by depletion
with MAb RB6-8C5, which recognizes the myeloid differenti-
ation antigen 1 (Gr1) that is abundant on mature granulocytes
(15). Previously, studies demonstrated that treatment of mice
with the MAb RB6-8C5 increased susceptibility to the parasite
T. gondii, and it was suggested that this might reflect an im-
portant role of neutrophils, which strongly express Ly6G (5,
26). RB6-8C5 has also been used for depletion studies to
explore the role of cellular immunity to Leishmania infantum,
Leishmania major, Plasmodium berghei ANKA, and Trypano-
soma cruzi (8–10, 25). However, later studies revealed that
inflammatory monocytes are also stained by RB6 (Gr1) due to
expression of Ly6C (18). Hence, these depletion studies would
be more accurately interpreted as demonstrating a possible
role for neutrophils and/or inflammatory monocytes.
The recent description of MAb 1A8 that specifically recog-
nizes Ly6G has allowed the role of neutrophils to be studied
using more precise depletion protocols (12). As in a previous
report (12), we observed that RB6-8C5 depleted both inflam-
matory monocytes and neutrophils, while 1A8 selectively de-
pleted neutrophils in mice. Daily treatment with MAb 1A8 was
required to effectively deplete neutrophils from both circula-
tion and lymphatic organs. To evaluate the role of inflamma-
tory monocytes and neutrophils in acute infection, mice were
orally treated with T. gondii, and then antibodies were used to
selectively deplete cellular subsets. Depletion with MAb RB6-
8C5 greatly increased susceptibility for T. gondii infection. In
contrast, depletion of neutrophils with MAb 1A8 had little
effect on survival. Ccr2/ mice suffered from extensive necro-
sis of the small intestine and spleen, and marked infiltration of
neutrophils and parasites were observed. Pathological changes
were associated with extensive neutrophil infiltration, suggest-
ing that they contribute more to tissue damage than to host
protection. Consistent with this interpretation, treatment of
Ccr2/ mice with MAb 1A8 reduced neutrophil influx, re-
duced tissue damage, and reduced inflammatory cytokine lev-
els. Similarly, damage to the small intestine following oral
infection with T. gondii is decreased by the genetic absence of
IL-17R, implicating a role for neutrophils in this pathology
(20). Our findings support the conclusion that inflammatory
FIG. 4. Survival of mice following oral infection with T. gondii.
(A) Mice were infected with 20 cysts of type II gondii (PRU-Luc-
GFP), and survival was monitored for 25 days. The majority of
infected control mice (WT control) and MAb 1A8-treated mice
(WT  1A8) survived. Ccr2/ mice, Ccr2/ mice treated with
MAb 1A8 (Ccr2 /  1A8), and MAb RB6-8C5-treated mice
(WT  RB6) all died within 14 days after infection. Antibodies
were applied daily from days 0 to 5. Data are combined from five
individual experiments, with 12 to 16 total animals per group.
(B) Bioluminescence tracking of parasite dissemination. Luciferase
imaging revealed control mice (WT control) and mice treated with
1A8 MAb (WT  1A8) controlled the infection. In contrast,
Ccr2/ mice, Ccr2/ mice treated with MAb 1A8 (Ccr2/ 
1A8), and MAb RB6-8C5-treated mice (WT  RB6) were not able
to control parasite replication. This figure shows one representative
experiment (mean 	 SD; 3 to 4 animals per group) from five similar
experiments.
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monocytes are essential for survival of mice infected with T.
gondii, while the lack of neutrophils had no effect of the sus-
ceptibility but rather contribute to pathology.
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